These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19183107)

  • 1. Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.
    Yang X; Koh CG; Liu S; Pan X; Santhanam R; Yu B; Peng Y; Pang J; Golan S; Talmon Y; Jin Y; Muthusamy N; Byrd JC; Chan KK; Lee LJ; Marcucci G; Lee RJ
    Mol Pharm; 2009; 6(1):221-30. PubMed ID: 19183107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes.
    Chiu SJ; Liu S; Perrotti D; Marcucci G; Lee RJ
    J Control Release; 2006 May; 112(2):199-207. PubMed ID: 16564596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model.
    Zhang X; Koh CG; Yu B; Liu S; Piao L; Marcucci G; Lee RJ; Lee LJ
    Pharm Res; 2009 Jun; 26(6):1516-24. PubMed ID: 19291371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing.
    Koh CG; Zhang X; Liu S; Golan S; Yu B; Yang X; Guan J; Jin Y; Talmon Y; Muthusamy N; Chan KK; Byrd JC; Lee RJ; Marcucci G; Lee LJ
    J Control Release; 2010 Jan; 141(1):62-9. PubMed ID: 19716852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia.
    Jin Y; Liu S; Yu B; Golan S; Koh CG; Yang J; Huynh L; Yang X; Pang J; Muthusamy N; Chan KK; Byrd JC; Talmon Y; Lee LJ; Lee RJ; Marcucci G
    Mol Pharm; 2010 Feb; 7(1):196-206. PubMed ID: 19852511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Polyethylenimine-Containing and Transferrin-Conjugated Lipid Nanoparticle System for Antisense Oligonucleotide Delivery to AML.
    Yuan Y; Zhang L; Cao H; Yang Y; Zheng Y; Yang XJ
    Biomed Res Int; 2016; 2016():1287128. PubMed ID: 27034925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer.
    Cheng X; Liu Q; Li H; Kang C; Liu Y; Guo T; Shang K; Yan C; Cheng G; Lee RJ
    Pharm Res; 2017 Feb; 34(2):310-320. PubMed ID: 27896589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coaxial electrohydrodynamic spraying: a novel one-step technique to prepare oligodeoxynucleotide encapsulated lipoplex nanoparticles.
    Wu Y; Yu B; Jackson A; Zha W; Lee LJ; Wyslouzil BE
    Mol Pharm; 2009; 6(5):1371-9. PubMed ID: 19499922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient delivery of the Bcl-2 antisense oligonucleotide G3139 via nucleus-targeted aCD33-NKSN nanoparticles.
    Yan C; Gu J; Zhang Y; Ma K; Lee RJ
    Int J Pharm; 2022 Sep; 625():122074. PubMed ID: 35932928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cells.
    Lai JC; Benimetskaya L; Khvorova A; Wu S; Hua E; Miller P; Stein CA
    Mol Cancer Ther; 2005 Feb; 4(2):305-15. PubMed ID: 15713901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
    Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
    Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: relationship to the decreased viability of T24 bladder and PC3 prostate cancer cells.
    Benimetskaya L; Miller P; Benimetsky S; Maciaszek A; Guga P; Beaucage SL; Wilk A; Grajkowski A; Halperin AL; Stein CA
    Mol Pharmacol; 2001 Dec; 60(6):1296-307. PubMed ID: 11723237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL-2 antisense oligonucleotide genasense is active against imatinib-resistant BCR-ABL-positive cells.
    Tauchi T; Sumi M; Nakajima A; Sashida G; Shimamoto T; Ohyashiki K
    Clin Cancer Res; 2003 Sep; 9(11):4267-73. PubMed ID: 14519654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of G3139 lipid nanoparticles (LNPs).
    Pan X; Chen L; Liu S; Yang X; Gao JX; Lee RJ
    Mol Pharm; 2009; 6(1):211-20. PubMed ID: 19072654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfide-linked liposomes: effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139.
    Weecharangsan W; Yu B; Liu S; Pang JX; Lee LJ; Marcucci G; Lee RJ
    Anticancer Res; 2010 Jan; 30(1):31-7. PubMed ID: 20150614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft.
    Spugnini EP; Biroccio A; De Mori R; Scarsella M; D'Angelo C; Baldi A; Leonetti C
    J Transl Med; 2011 Jul; 9():125. PubMed ID: 21798045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G3139 induces cell death by caspase-dependent and -independent apoptosis on human melanoma cell lines.
    Nakamura S; Inui M; Kamei T; Nakase M; Okumura K; Tagawa T
    Oncol Rep; 2006 Jun; 15(6):1563-8. PubMed ID: 16685396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression.
    Chi KC; Wallis AE; Lee CH; De Menezes DL; Sartor J; Dragowska WH; Mayer LD
    Breast Cancer Res Treat; 2000 Oct; 63(3):199-212. PubMed ID: 11110054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.